Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:42 AM UTC
| NCT Number | NCT05651932 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 165 participants |
| Active Locations | 17 sites in the US |
| Sponsor | K36 Therapeutics, Inc. |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT05651932 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 17 locations across the United States. The study is sponsored by K36 Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05651932 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05651932 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.